Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Cell Physiol Biochem ; 26(2): 197-208, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20798503

RESUMO

UNLABELLED: Cell swelling-induced insulin secretion represents an alternative pathway of stimulation of insulin secretion. INS-1E rat tumor beta cells do not release insulin in response to cell swelling in presence of Ca(2+) despite a good response to glucose challenge and appropriate increase in cell volume. Surprisingly, perifusion with Ca(2+)-depleted medium showed distinct secretory response of INS-1E cells to hypotonicity. Objective of this study was further characterization of the role of Ca(2+) in secretory process in INS-1 and INS-1E cell lines. Ca(2+) depleted hypotonic medium with 10 muM BAPTA/AM (intracellular chelator) induced insulin secretion from both types of cells. We demonstrated expression of L-type Ca(2+) channel Ca(v)1.2 and non-L-type Ca(2+) channels Ca(v)2.1 (P/Q-type), Ca(v)2.2 (N-type), and Ca(v)3.1 (T-type) in both cell lines. Inhibition of L type channel with nifedipine and/or P/Q type with omega-agatoxin IVA enabled distinct response to hypotonic medium also in INS-1E cells. Tetanus toxin (TeTx) in medium containing Ca(2+) and a group of calcium channel blockers inhibited hypotonicity-induced insulin secretion from INS-1 cells but not from INS-1E cells. CONCLUSION: Hypotonicity-induced insulin secretion from INS-1E cells is inhibited by extracellular Ca(2+), does not require intracellular Ca(2+) and is TeTx resistant.


Assuntos
Cálcio/farmacologia , Insulina/metabolismo , Toxina Tetânica/farmacologia , Animais , Bloqueadores dos Canais de Cálcio/farmacologia , Canais de Cálcio Tipo L/química , Canais de Cálcio Tipo L/genética , Canais de Cálcio Tipo L/metabolismo , Canais de Cálcio Tipo P/química , Canais de Cálcio Tipo P/genética , Canais de Cálcio Tipo P/metabolismo , Canais de Cálcio Tipo Q/química , Canais de Cálcio Tipo Q/genética , Canais de Cálcio Tipo Q/metabolismo , Canais de Cálcio Tipo R/química , Canais de Cálcio Tipo R/genética , Canais de Cálcio Tipo R/metabolismo , Canais de Cálcio Tipo T/química , Canais de Cálcio Tipo T/genética , Canais de Cálcio Tipo T/metabolismo , Linhagem Celular Tumoral , Tamanho Celular , Ácido Egtázico/análogos & derivados , Ácido Egtázico/farmacologia , Soluções Hipotônicas/química , Secreção de Insulina , Masculino , Nifedipino/farmacologia , Ratos , Proteínas SNARE/metabolismo , Proteínas SNARE/fisiologia , ômega-Agatoxina IVA/farmacologia
2.
Neuron ; 39(6): 951-60, 2003 Sep 11.
Artigo em Inglês | MEDLINE | ID: mdl-12971895

RESUMO

L-type (CaV1.2) and P/Q-type (CaV2.1) calcium channels possess lobe-specific CaM regulation, where Ca2+ binding to one or the other lobe of CaM triggers regulation, even with inverted polarity of modulation between channels. Other major members of the CaV1-2 channel family, R-type (CaV2.3) and N-type (CaV2.2), have appeared to lack such CaM regulation. We report here that R- and N-type channels undergo Ca(2+)-dependent inactivation, which is mediated by the CaM N-terminal lobe and present only with mild Ca2+ buffering (0.5 mM EGTA) characteristic of many neurons. These features, together with the CaM regulatory profiles of L- and P/Q-type channels, are consistent with a simplifying principle for CaM signal detection in CaV1-2 channels-independent of channel context, the N- and C-terminal lobes of CaM appear invariably specialized for decoding local versus global Ca2+ activity, respectively.


Assuntos
Canais de Cálcio/genética , Canais de Cálcio/metabolismo , Cálcio/metabolismo , Calmodulina/metabolismo , Sequência de Aminoácidos , Animais , Canais de Cálcio/química , Canais de Cálcio Tipo L/química , Canais de Cálcio Tipo L/genética , Canais de Cálcio Tipo L/metabolismo , Canais de Cálcio Tipo N/química , Canais de Cálcio Tipo N/genética , Canais de Cálcio Tipo N/metabolismo , Canais de Cálcio Tipo P/química , Canais de Cálcio Tipo P/genética , Canais de Cálcio Tipo P/metabolismo , Canais de Cálcio Tipo Q/química , Canais de Cálcio Tipo Q/genética , Canais de Cálcio Tipo Q/metabolismo , Canais de Cálcio Tipo R/química , Canais de Cálcio Tipo R/genética , Canais de Cálcio Tipo R/metabolismo , Bovinos , Linhagem Celular , Relação Dose-Resposta a Droga , Humanos , Dados de Sequência Molecular , Ratos , Homologia de Sequência de Aminoácidos
3.
J Neurosci ; 19(12): RC14, 1999 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-10366652

RESUMO

Spinocerebellar ataxia 6 (SCA6) is caused by expansion of a polyglutamine stretch, encoded by a CAG trinucleotide repeat, in the human P/Q-type Ca(2+) channel alpha(1A) subunit. Although SCA6 shares common features with other neurodegenerative glutamine repeat disorders, the polyglutamine repeats in SCA6 are exceptionally small, ranging from 21 to 33. Because this size is too small to form insoluble aggregates that have been blamed for the cause of neurodegeneration, SCA6 is the disorder suitable for exploring the pathogenic mechanisms other than aggregate formation, whose universal role has been questioned. To characterize the pathogenic process of SCA6, we studied the effects of polyglutamine expansion on channel properties by analyzing currents flowing through the P/Q-type Ca(2+) channels with an expanded stretch of 24, 30, or 40 polyglutamines, recombinantly expressed in baby hamster kidney cells. Whereas the Ca(2+) channels with

Assuntos
Canais de Cálcio Tipo P/fisiologia , Canais de Cálcio Tipo Q/fisiologia , Peptídeos/química , Animais , Apoptose , Canais de Cálcio Tipo P/química , Canais de Cálcio Tipo P/metabolismo , Canais de Cálcio Tipo Q/química , Canais de Cálcio Tipo Q/metabolismo , Linhagem Celular , Cricetinae , Humanos , Potenciais da Membrana , Técnicas de Patch-Clamp , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Ataxias Espinocerebelares/metabolismo
4.
FEBS Lett ; 491(1-2): 127-30, 2001 Feb 23.
Artigo em Inglês | MEDLINE | ID: mdl-11226434

RESUMO

As replacement of Thr(11) of omega-conotoxin MVIIC with Ala significantly reduced the affinity for both N- and P/Q-type calcium channels, we examined the effect of substitution at this position with other residues. Binding assays using rat cerebellar P2 membranes showed that the affinity is in the order of Leu>Val, aminobutyric acid, Thr>Asn&z.Gt;Ser, Ala, Asp, Phe, Tyr for N-type channels and Thr>Leu, Val, aminobutyric acid, Asn, Ser>Ala&z.Gt;Asp, Phe, Tyr for P/Q-type channels, suggesting that aliphatic amino acids with longer side chains are favorable for block of N-type channels. The effects of substitution were examined electrophysiologically in BHK cells expressing N-type Ca2+ channels. Inhibition of Ba2+ current by the analogs did not completely correlate with binding affinity, although binding to BHK cells was comparable to rat cerebellar membranes.


Assuntos
Alanina/química , Bloqueadores dos Canais de Cálcio/metabolismo , Canais de Cálcio Tipo N/metabolismo , Treonina/química , ômega-Conotoxinas/metabolismo , Sequência de Aminoácidos , Animais , Bário/metabolismo , Bloqueadores dos Canais de Cálcio/química , Canais de Cálcio Tipo N/química , Canais de Cálcio Tipo P/química , Canais de Cálcio Tipo P/metabolismo , Canais de Cálcio Tipo Q/química , Canais de Cálcio Tipo Q/metabolismo , Células Cultivadas , Cricetinae , Dados de Sequência Molecular , Técnicas de Patch-Clamp , Ligação Proteica , Ratos , ômega-Conotoxinas/química
5.
FEBS Lett ; 528(1-3): 177-82, 2002 Sep 25.
Artigo em Inglês | MEDLINE | ID: mdl-12297300

RESUMO

Gabapentin (GBP) is a gamma-aminobutyric acid analog effective in the treatment of seizures. A high-affinity interaction between GBP and the alpha(2)delta subunit of the voltage-gated Ca(2+) channels has been documented. In this report, we examined the effects of the chronic treatment with GBP on neuronal recombinant P/Q-type Ca(2+) channels expressed in Xenopus oocytes. GBP did not affect significantly the amplitude or the voltage dependence of the currents. Exposure to the drug did, however, slow down the kinetics of inactivation in a dose-dependent fashion. In addition, biochemical analysis showed that the integrity of Ca(2+) channel complex is not apparently affected by GBP binding, suggesting that chronic treatment with the drug might cause the channel kinetic modification through subtle conformational changes of the protein complex.


Assuntos
Acetatos/farmacologia , Aminas , Canais de Cálcio Tipo P/efeitos dos fármacos , Canais de Cálcio Tipo P/metabolismo , Canais de Cálcio Tipo Q/efeitos dos fármacos , Canais de Cálcio Tipo Q/metabolismo , Ácidos Cicloexanocarboxílicos , Ácido gama-Aminobutírico , Animais , Anticonvulsivantes/farmacologia , Encéfalo/metabolismo , Canais de Cálcio Tipo P/química , Canais de Cálcio Tipo Q/química , Feminino , Gabapentina , Técnicas In Vitro , Cinética , Oócitos/metabolismo , Conformação Proteica/efeitos dos fármacos , Coelhos , Ratos , Proteínas Recombinantes/química , Proteínas Recombinantes/efeitos dos fármacos , Proteínas Recombinantes/metabolismo , Convulsões/tratamento farmacológico , Convulsões/metabolismo , Xenopus laevis
6.
J Mol Endocrinol ; 24(2): 225-32, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10750023

RESUMO

The omega-agatoxin-IVA-sensitive P/Q-type Ca(2+) channel plays a role in insulin release from the pancreatic islets of beta cells. To dissect the molecular mechanisms underlying beta cell expression of the P/Q-type channel, we characterized the 5'-upstream region of the mouse alpha(1A) subunit gene using transgenic mice and HIT insulinoma cells. The E. coli lacZ reporter gene was expressed in pancreatic acini and islets in transgenic mice carrying the 6.3 kb or 3.0 kb of the 5'-upstream region, although those with 1.5 kb or 0. 5 kb of the 5'-upstream region failed to show reporter expression on histological examination. As the expression of alpha(1A)subunit gene could not be detected in acini using RT-PCR analysis, the reporter expression in acini might have been ectopic expression. When linked to the placental alkaline phosphatase reporter gene to examine promoter activity for beta cell expression, the 6.3 kb and 3.0 kb fragment of the 5'-upstream region, but not the smaller 1.5 kb fragment, were able to drive reporter gene expression in HIT cells. The sequence between 3.0 and 1.5 kb upstream of the start codon enhanced thymidine kinase promoter activity in HIT cells, but not in fibroblast NIH3T3 cells. These results suggested that the beta cell-specific elements of the alpha(1A) subunit gene are likely to be located in the distal upstream region (-3021 to-1563) of the 5'-upstream sequence and that the 6.3 kb fragment of the 5'-upstream region alone might be a lack of a negative cis-regulatory element(s) to suppress the alpha(1A) subunit gene expression in acini.


Assuntos
Canais de Cálcio Tipo P/genética , Canais de Cálcio Tipo Q/genética , Ilhotas Pancreáticas/metabolismo , Animais , Canais de Cálcio Tipo P/química , Canais de Cálcio Tipo Q/química , Escherichia coli/genética , Genes Reporter , Insulinoma , Substâncias Macromoleculares , Camundongos , Camundongos Transgênicos , Pâncreas/metabolismo , Neoplasias Pancreáticas , RNA Mensageiro/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Transcrição Gênica , Transfecção/métodos , Células Tumorais Cultivadas , beta-Galactosidase/genética
7.
Neurosci Res ; 36(3): 183-91, 2000 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10683522

RESUMO

Lambert-Eaton myasthenic syndrome (LEMS), often associated with small cell lung carcinoma (SCLC), is a disease of neuromuscular transmission in which antibodies directed against voltage-gated calcium channel (VGCC) in the motor nerve terminal play a crucial role in causing a deficient quantal release of acetylcholine. We focused attention on the P/Q-type VGCC, against which a majority of LEMS patients carry the specific antibody. Since the P/Q-type VGCC expresses in SCLC, the motor nerve terminal and SCLC may share a common VGCC antigen. In search for antigenic sites at the molecular level, We employed peptides or recombinant protein corresponding to the S5-S6 linker of each of four domains forming the alpha 1A subunit and tested their antigenicity. As the result, we specified the domain II, III and IV as immunodominant sites by the induction of an immune-mediated animal model of LEMS and the assay for antibodies in LEMS patients. Also, by use of peptides or recombinant protein corresponding to the synaptotagmin I, we found that in this VGCC-associated protein, the segment which exposes extracellularly during exocytosis can be antigenic for LEMS.


Assuntos
Doenças Autoimunes/fisiopatologia , Canais de Cálcio Tipo Q/fisiologia , Proteínas de Ligação ao Cálcio , Síndrome Miastênica de Lambert-Eaton/fisiopatologia , Animais , Autoanticorpos/imunologia , Autoantígenos/imunologia , Doenças Autoimunes/imunologia , Canais de Cálcio Tipo Q/química , Canais de Cálcio Tipo Q/imunologia , Humanos , Síndrome Miastênica de Lambert-Eaton/imunologia , Glicoproteínas de Membrana/imunologia , Proteínas do Tecido Nervoso/imunologia , Sinaptotagmina I , Sinaptotagminas
8.
Biochem Biophys Res Commun ; 322(4): 1347-51, 2004 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-15336982

RESUMO

Lambert-Eaton myasthenic syndrome, often associated with small-cell lung carcinoma, is a disease of neuromuscular transmission in which antibodies directed against voltage-gated calcium channel (VGCC)(P/Q-type) in the motor nerve terminal play a crucial role in causing a deficient quantal release of acetylcholine. The motor nerve terminal and carcinoma cell may share a common antigen. The study using synthetic peptides and recombinant protein specified the extracellular S5-S6 linker regions in 3 of 4 domains as immunodominant sites in the molecular structure of P/Q-type VGCC alpha1 subunit. Also, the study by use of peptides and recombinant protein corresponding to synaptotagmin I suggested that in this functionally VGCC-associated presynaptic protein, the segment which exposes extracellularly during exocytosis can be immunogenic for the syndrome.


Assuntos
Canais de Cálcio Tipo P/imunologia , Canais de Cálcio Tipo Q/imunologia , Síndrome Miastênica de Lambert-Eaton/imunologia , Animais , Canais de Cálcio/imunologia , Canais de Cálcio Tipo P/química , Canais de Cálcio Tipo Q/química , Proteínas de Ligação ao Cálcio/imunologia , Modelos Animais de Doenças , Mapeamento de Epitopos , Humanos , Glicoproteínas de Membrana/imunologia , Camundongos , Proteínas do Tecido Nervoso/imunologia , Ratos , Sinaptotagmina I , Sinaptotagminas
9.
J Biol Chem ; 275(28): 21309-16, 2000 Jul 14.
Artigo em Inglês | MEDLINE | ID: mdl-10787403

RESUMO

The spider toxin omega-agatoxin IIIA (omega-Aga-IIIA) is a potent inhibitor of high voltage-activated calcium currents in the mammalian brain. To establish the biochemical parameters governing its action, we radiolabeled the toxin and examined its binding to native and recombinant calcium channels. In experiments with purified rat synaptosomal membranes, both kinetic and equilibrium data demonstrate one-to-one binding of omega-Aga-IIIA to a single population of high affinity sites, with K(d) = approximately 9 pm and B(max) = approximately 1.4 pmol/mg protein. Partial inhibition of omega-Aga-IIIA binding by omega-conotoxins GVIA, MVIIA, and MVIIC identifies N and P/Q channels as components of this population. omega-Aga-IIIA binds to recombinant alpha(1B) and alpha(1E) calcium channels with a similar high affinity (K(d) = approximately 5-9 pm) in apparent one-to-one fashion. Results from recombinant alpha(1B) binding experiments demonstrate virtually identical B(max) values for omega-Aga-IIIA and omega-conotoxin MVIIA, providing further evidence for a one-to-one stoichiometry of agatoxin binding to calcium channels. The combined evidence suggests that omega-Aga-IIIA defines a unique, high affinity binding site on N-, P/Q-, and R-type calcium channels.


Assuntos
Bloqueadores dos Canais de Cálcio/farmacocinética , Canais de Cálcio Tipo N/metabolismo , Neurônios/metabolismo , Venenos de Aranha/farmacocinética , Sinaptossomos/metabolismo , Agatoxinas , Animais , Encéfalo/metabolismo , Canais de Cálcio Tipo N/química , Canais de Cálcio Tipo P/química , Canais de Cálcio Tipo P/metabolismo , Canais de Cálcio Tipo Q/química , Canais de Cálcio Tipo Q/metabolismo , Canais de Cálcio Tipo R/química , Canais de Cálcio Tipo R/metabolismo , Linhagem Celular , Membrana Celular/metabolismo , Humanos , Membranas Intracelulares/metabolismo , Radioisótopos do Iodo , Cinética , Ratos , Ratos Sprague-Dawley , Proteínas Recombinantes/metabolismo , Aranhas , Transfecção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA